Award Data

This SBIR Phase I project will design, build, and test a web-based, modular curriculum for providing rigorous, accessible, and engaging computer science (CS) education to grades 9 - 10 students. The U.S. is experiencing two human resources gaps in computing. First, by 2020, the Bureau of Labor Statistics predicts there will be 1.2 million more CS related jobs than Americans trained to fill them. S ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is that it will enable the commercialization of a groundbreaking manufacturing process for pharmaceuticals. The project consists of the development of novel process technologies to manufacture drugs on a continuous basis (24 hours a day, 365 days a year), which is different from the current me ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to create custom crafted voices for text-to-speech applications that empower recipients to engage in conversation and be heard in his/her own voice. The company's technology blends a recipient's residual vocal abilities and a matched donor's speech database to craft a personalized voice tha ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to produce low-cost and customizable aromas that are inspired by plant extracts. The fragrance industry uses fragrant extracts from flowers and other plant materials as basic building blocks for haute-couture finished fragrances. These extracts are expensive due to the limited availability ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to increase global access to vaccines and reduce mortality associated with infectious diseases. As an example, Rotavirus is a major cause of severe gastroenteritis among young children and lack of vaccination results in 450,000 deaths annually. A thermostable rotavirus vaccine would cr ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide antibody engineers with a user-friendly computational platform to assist in the design and engineering of therapeutic antibodies. Antibody-based drugs are becoming the treatment of choice for diverse diseases such as multiple sclerosis, rheumatoid arthritis, and several types of ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is embodied in the project's anticipated advance of the state-of-the art in controlled release technology, where there is a compelling need for sustained treatment in a range of medical conditions and diseases. The feasibility of the proposed technology has already been demonstrated in several ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a new diagnostic platform technology that is faster, more sensitive, and lower cost as compared with current diagnostic tests. Faster diagnostic results will improve hospital care by quickly and accurately isolating infectious patients and preventing co-infections. Current in-vitro diagn ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the enablement of new and improved therapeutic drug development. One hurdle in the development of new drugs, is their relatively low effectiveness due to poor water solubility limiting formulation choices and/or limiting cellular uptake. Forming drug nano particles, by way of controlling th ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to address a major barrier in fundamental biological research and next-generation clinical treatments: Delivering materials into cells. Cells are the basic functional unit of the body yet understanding their role in disease and harnessing their inherent potential to combat ailments has been limited ...